Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: Prolonged intrathoracic tumor control and high central nervous system relapse rate
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/10/9/1051/19477701/10-9-1051.pdf
Reference41 articles.
1. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: A randomized trial of the Southeastern Cancer Study Group;Johnson;J Clin Oncol,1993
2. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide–cisplatin followed by cyclophosphamide doxorubicin and vincristine;Johnson;J Clin Oncol,1996
3. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer;Murray;J Clin Oncol,1993
4. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer;Gregor;A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group study. J Clin Oncol,1997
5. Concurrent chemotherapy/radiotherapy for limited small-cell carcinoma of the lung: A Southwest Oncology Group Study;McCracken;J Clin Oncol,1990
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Timing of Failure in Limited Disease (Stage I-III) Small-Cell Lung Cancer Patients Treated with Chemoradiotherapy: A Retrospective Analysis;Tumori Journal;2013-11
2. Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival;Journal of Neuro-Oncology;2012-05-20
3. Solid tumors in adults;Hematopoietic Stem Cell Transplantation in Clinical Practice;2009
4. Current Status of Clinical Trials for Small Cell Lung Cancer;Reviews on Recent Clinical Trials;2008-01-01
5. Increasing Chemotherapy in Small-Cell Lung Cancer: From Dose Intensity and Density to Megadoses;The Oncologist;2007-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3